An Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice

Not yet recruitingOBSERVATIONAL
Enrollment

169

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Chronic Cholecystitis
Trial Locations (15)

055990

"Human Health Clinic LLP", Almaty

"JSC Research institute of cardiology and internal disease", Almaty

State-owned public enterprise with the right of economic management City Clinic No. 5, Almaty

Unknown

"Taimas Medical LLP", Astana

"Medical center Aiya", Astana

Medical Center Hospital of the President's affairs Administration of the Republic of Kazakhstan, Astana

"NpJSC Astana Medical University", Astana

"State-owned public enterprise with the right of economic management Multidisciplinary regional hospital of the Kyzylorda Region Health Department", Kyzylorda

"Treatment Center No. 14 LLP", Shymkent

City diagnostic center of Shymkent, Shymkent

"Medical Center Aesculapius Vita", Shymkent

"State-owned public enterprise with the right of economic management District polyclinic Sauran of the Department of Public Health of the Turkestan region", Shymkent

"Comec Medical Company Llp", Taraz

"Hayat Medical Group LLP Diagnostic Center", Taraz

"Medical Center Meyirim", Taraz

All Listed Sponsors
lead

Kazakhstan Scientific Society for Study of intestine diseases

OTHER

NCT06516718 - An Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice | Biotech Hunter | Biotech Hunter